India has launched an investigation into the death of 18 children in Uzbekistan after they consumed an Indian-manufactured cough syrup, as one of the world’s biggest drug exporters faces increasing scrutiny over the quality of medicines it produces.
In a statement on Thursday, India’s health ministry said the Central Drugs Standard Control Organisation (CDSCO) — the country’s drug regulatory authority — was communicating with its counterpart in Uzbekistan over the incident.
